ICAM1 and COVID-19: The level of the cell adhesion molecule ICAM-1 was increased in the female COVID-19 patients at diagnosis and was further generally increased in all COVID-19 patients at follow-up, though the increase was greater in females (p < 0.001, Figure 3A).